The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification

How I treat primary CNS lymphoma

(2011) A. J. M. Ferreri   BLOOD

Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma

(2011) S. D. Dojcinov et al.   BLOOD

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

(2011) G. Gutierrez-Garcia et al.   BLOOD

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

(2011) G. Salles et al.   BLOOD

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

(2011) E. Campo et al.   BLOOD

Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice

(2011) Anwaar Ahmad et al.   CANCER BIOLOGY & THERAPY

Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma

(2011) Madhavi Challa-Malladi et al.   CANCER CELL

EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals

(2011) Brady E. Beltran et al.   Clinical Lymphoma Myeloma & Leukemia

Molecular signatures in the diagnosis and management of diffuse large B-cell lymphoma

(2011) John W Sweetenham   CURRENT OPINION IN HEMATOLOGY

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype

(2011) W. H. Wilson et al.   HAEMATOLOGICA

Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma

(2011) F. C. Eberle et al.   HAEMATOLOGICA

Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations

(2011) Franziska C Eberle et al.   MODERN PATHOLOGY

Analysis of the coding genome of diffuse large B-cell lymphoma

(2011) Laura Pasqualucci et al.   NATURE GENETICS

Early Accelerated Approval for Highly Targeted Cancer Drugs

(2011) Bruce A. Chabner   NEW ENGLAND JOURNAL OF MEDICINE

Primary Mediastinal DLBCL: Evolving Biologic Understanding and Therapeutic Strategies

(2011) Pier Luigi Zinzani et al.   Current Oncology Reports

Aggressive B-Cell Lymphomas: A Review of New and Old Entities in the WHO Classification

(2011) E. S. Jaffe et al.   Hematology-American Society of Hematology Education Program

B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma

(2010) Matija Snuderl et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression

(2010) Stefan D. Dojcinov et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma

(2010) C. O. Sung et al.   BLOOD

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

(2010) M. R. Green et al.   BLOOD

MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF- B-dependent lymphoma

(2010) M. A. Milhollen et al.   BLOOD

Double-hit B-cell lymphomas

(2010) S. M. Aukema et al.   BLOOD

Cooperative Epigenetic Modulation by Cancer Amplicon Genes

(2010) Lixin Rui et al.   CANCER CELL

Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas

(2010) C. Bedwell et al.   HAEMATOLOGICA

T-cell/histiocyte-rich large B-cell lymphoma

(2010) S. Pittaluga et al.   HAEMATOLOGICA

Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children

(2010) I. Oschlies et al.   HAEMATOLOGICA

Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

(2010) Sharon Barrans et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

(2010) Paul N. Meyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features

(2010) Lekidelu Taddesse-Heath et al.   MODERN PATHOLOGY

Diffuse large B-cell lymphoma associated with chronic inflammation as an incidental finding and new clinical scenarios

(2010) Florence Loong et al.   MODERN PATHOLOGY

Oncogenically active MYD88 mutations in human lymphoma

(2010) Vu N. Ngo et al.   NATURE

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

(2010) R. Eric Davis et al.   NATURE

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

(2009) K. Dunleavy et al.   BLOOD

Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

(2009) N. A. Johnson et al.   BLOOD

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

(2009) K. J. Savage et al.   BLOOD

A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy

(2009) W. W.L. Choi et al.   CLINICAL CANCER RESEARCH

T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response

(2009) P. Van Loo et al.   HAEMATOLOGICA

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

(2009) N. Tomita et al.   HAEMATOLOGICA

Anaplastic Lymphoma Kinase–Positive Diffuse Large B-Cell Lymphoma: A Rare Clinicopathologic Entity With Poor Prognosis

(2009) Camille Laurent et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP

(2009) Heidi Nyman et al.   MODERN PATHOLOGY

Pathway analysis of primary central nervous system lymphoma

(2008) H. W. Tun et al.   BLOOD

Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

(2008) N. Asano et al.   BLOOD

Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors

(2008) Ana Gabrea et al.   GENES CHROMOSOMES & CANCER

Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

(2008) D. de Jong et al.   JOURNAL OF CLINICAL PATHOLOGY

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways

(2008) M Booman et al.   JOURNAL OF PATHOLOGY

Stromal Gene Signatures in Large-B-Cell Lymphomas

(2008) G. Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

(2008) G. Lenz et al.   SCIENCE